MULTIDRUG RESISTANCE PROTEIN 1 (ABCC1))

ABC Proteins: from Bacteria to Man

Volumn , Issue , 2003, Pages 393-422

  Deeley, Roger G ^a   Cole, Susan P C ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891539797     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012352551-2/50020-2     Document Type: Chapter

References (161)

1. M.R. Abbaszadegan, B.W. Futscher, W.T. Klimecki, A. List and W.S. Dalton (1994) Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res. 54 4676-4679.
2. K.C. Almquist, D.W. Loe, D.R. Hipfner, J.E. Mackie, S.P.C. Cole and R.G. Deeley (1995) Characterization of the 190 kDa multidrug resistance protein (MRP) in drug-selected and transfected human tumor cells. Cancer Res. 55 102-110.
3. S.V. Ambudkar, S. Dey, C.A. Hyrcyna, M. Ramachandra, I. Pastan and M.M. Gottesman (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39 361-398.
4. P. Bader, F. Schilling, M. Schlaud, R. Girgert, R. Handgretinger, T. Klingebiel, J. Treuner, C. Liu, D. Niethammer and J.F. Beck (1999) Expression analysis of multdrug resistance associated genes in neuroblastomas. Oncology Reports 6 1143-1146.
5. E. Bakos, T. Hegedus, Z. Hollo, E. Welker, G.E. Tusnady, G.J.R. Zaman, M.J. Flens, A. Varadi and B. Sarkadi (1996) Membrane topology and glycosylation of the human multidrug resistance-associated protein. J. Biol. Chem. 271 12322-12326.
6. E. Bakos, R. Evers, G. Szakacs, G.E. Tusnady, E. Welker, K. Szabo, et al. (1998) Functionalmultidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain. J. Biol. Chem. 273 32167-32175.
7. E. Bakos, R. Evers, G. Calenda, G.E. Tusnady, G. Szakacs, A. Varadi and B. Sarkadi (2000) Characterization of the aminoterminal regions in the human multidrug resistance protein (MRP1). J. Cell Sci. 113 4451-4461.
8. E. Bakos, R. Evers, J.A. Sinkule, A. Varadi, P. Borst and B. Sarkadi (2000) Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol. Pharmacol. 57 760-768.
9. K. Barnouin, L. Leier, G. Jedlitschky, A. Pourtier-Manzanedo, J. Konig, W.-D. Lehmann and D. Keppler (1998) Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione. Br. J. Cancer 77 201-209.
10. P. Borst, R. Evers, M. Kool and J. Wijnholds (1999) The multidrug resistance protein family. Biochim. Biophys. Acta 1461 347-357.
11. J.-M. Brechot, I. Hurgain, A. Fajac, N. Daty and J.-F. Bernaudin (1998) Different pattern of MRP localization in ciliated and basal cells from human bronchial epithelium. J. Histochem. Cytochem. 46 513-517.
12. H.S.L. Chan, Y. Lu, T.M. Grogan, G. Haddad, D.R. Hipfner, S.P.C. Cole, R.G. Deeley, V. Ling and B.L. Gallie (1997) Multidrug resistance protein (MRP) expression in retinoblastoma correlates with rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein. Cancer Res. 57 2325-2330.
13. X.-B. Chang, Y.-X. Hou and J.R. Riordan (1997) ATPase activity of purified multidrug resistance-associated protein. J. Biol. Chem. 272 30962-30968.
14. Z. Chen, M. Mutoh, T. Sumizawa, T. Furukawa, M. Haraguchi, A. Tani and S. Akiyama (1997) Reversal of heavy metal resistance in multidrug-resistant human KB carcinoma cells. Biochem. Biophys. Res. Commun. 236 586-590.
15. S.P.C. Cole (1990) Patterns of cross-resistance in a multidrug-resistant small-cell lung carcinoma cell line. Cancer Chemother. Pharmacol. 26 250-256.
16. S.P.C. Cole (1992) Drug resistance and lung cancer. J. Wood (Eds) Cancer: Concept to Clinic Fairlawn, NJ: Medical Publishing Enterprises 15-21.
17. S.P.C. Cole and R.G. Deeley (1996) Multidrug resistance associated with overexpression of MRP. W.N. Hait (Eds) Drug Resistance Norwell, MA: Kluwer Academic Press 39-62.
18. S.P.C. Cole and R.G. Deeley (1998) Multidrug resistance mediated by the ATP-binding cassette transporter protein, MRP. BioEssays 20 931-940.
19. S.P.C. Cole, H.F. Downes and M.L. Slovak (1989) Effect of calcium antagonists on the chemosensitivity of two multidrug resistant human tumour cell lines which do not overexpress P-glycoprotein. Br. J. Cancer 59 42-46.
20. S.P.C. Cole, G. Bhardwaj, J.H. Gerlach, J.E. Mackie, C.E. Grant, K.C. Almquist, A.J. Stewart, E.U. Kurz, A.M.V. Duncan and R.G. Deeley (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258 1650-1654.
21. S.P.C. Cole, K.E. Sparks, K. Fraser, D.W. Loe, C.E. Grant, G.M. Wilson and R.G. Deeley (1994) Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 54 5902-5910.
22. S. Conrad, H.-M. Kaufmann, K.-I. Ito, R. Deeley, S.P.C. Cole and D. Schrenk (2001) Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution. J. Hum. Genet. 46 656-663.
23. Y. Cui, J. Konig, U. Buchholz, H. Spring, I. Leier and D. Keppler (1999) Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol. Pharmacol. 55 929-937.
24. R. Daoud, J. Desneves, L.W. Deady, L. Tilley, R.J. Scheper, P. Gros and E. Georges (2000) The multidrug resistance protein is photoaffinity labeled by a quinoline-based drug at multiple sites. Biochemistry 39 6094-6102.
25. M.C. de Jong, J.W. Slootstra, G.L. Scheffer, A.B. Schroeijers, W.C. Puijk, R. Dinkelberg, M. Kool, H.J. Broxterman, R.H. Meloen and R.J. Scheper (2001) Peptide transport by the multidrug resistance protein MRP1. Cancer Res. 61 2552-2557.
26. R.G. Deeley and S.P.C. Cole (1997) Multidrug resistance in mammalian cells mediated by members of the ATP-binding cassette superfamily: the P-glycoproteins and MRP. Molecular Genetics of Drug Resistance Harwood Academic Press 247-298.
27. M.L. den Boer, C.M. Zwaan, R. Pieters, K.M. Kazemier, M.M.A. Rottier, M.J. Flens, R.J. Scheper and A.J.P. Veerman (1997) Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia. Leukemia 11 1078-1085.
28. S. Dey, M. Ramachandra, I. Pastan, M.M. Gottesman and S.V. Ambudkar (1997) Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. Proc. Natl Acad. Sci. USA 94 10594-10599.
29. S.K. Diah, P.K. Smitherman, A.J. Townsend and C.S. Morrow (1999) Detoxification of 1-chloro-2,4-dinitrobenzene in MCF7 breast cancer cells expressing glutathione S-transferase P1-1 and/or multidrug resistance protein 1. Tox. Appl. Pharmacol. 157 85-93.
30. L.A. Doyle, W. Yang, L.V. Abruzzo, I. Krogmann, Y. Gao, A.K. Rishi and D.D. Ross (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl Acad. Sci. USA 95 15665-15670.
31. R. Evers, N.H.P. Cnubben, J. Wijnholds, L. van Deemter, P.J. van Bladeren and P. Borst (1997) Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1. FEBS Lett. 419 112-116.
32. M. Filipits, R.W. Suchomel, G. Dekan, K. Haider, G. Valdimarsson, D. Depisch and R. Pirker (1996) MRP and MDR1 gene expression in primary breast carcinoma. Clin. Cancer Res. 2 1231-1237.
33. M.J. Flens, G.J.R. Zaman, P. van der Valk, M.A. Izquierdo, A.B. Schroeijers, G.L. Scheffer, P. van der Groep, M. de Haas, C.J.L.M. Meijer and R.J. Scheper (1996) Tissue distribution of the multidrug resistance-associated protein. Am. J. Pathol. 148 1237-1247.
34. M. Gao, D.W. Loe, C.E. Grant, S.P.C. Cole and R.G. Deeley (1996) Reconstitution of ATP-dependent LTC4 transport by coexpression of both half-molecules of human MRP in insect cells. J. Biol. Chem. 271 27782-27787.
35. M. Gao, M. Yamazaki, D.W. Loe, C.J. Westlake, C.E. Grant, S.P.C. Cole and R.G. Deeley (1998) Multidrug Resistance Protein: Identification of regions required for active transport of leukotriene C4. J. Biol. Chem. 273 10733-10740.
36. M. Gao, H.-R. Cui, D.W. Loe, C.E. Grant, K.C. Almquist, S.P.C. Cole and R.G. Deeley (2000) Comparison of the functional characteristics of the nucleotide binding domains of multidrug resistance protein 1. J. Biol. Chem. 275 13098-13108.
37. H. Goto, N. Keshelava, K.K. Matthay, J.N. Lukens, R.B. Gerbing, D.O. Stram, R.C. Seeger and C.P. Reynolds (2000) Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors. Med. Pediatr. Oncol. 35 619-622.
38. C.E. Grant, G. Valdimarsson, D.R. Hipfner, K.C. Almquist, S.P.C. Cole and R.G. Deeley (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 54 357-361.
39. C.E. Grant, E.U. Kurz, S.P.C. Cole and R.G. Deeley (1997) Analysis of the intronexon organization of the multidrug resistance protein (MRP) gene and alternative splicing of its mRNA. Genomics 45 368-378.
40. M. Heijn, J.H. Hoojiberg, G.L. Scheffer, G. Szabo, H.V. Westerhoff and J. Lankelma (1997) Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport. Biochim. Biophys. Acta 1326 12-22.
41. D.R. Hipfner, S.D. Gauldie, R.G. Deeley and S.P.C. Cole (1994) Detection of the M r 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res. 54 5788-5792.
42. D.R. Hipfner, K.C. Almquist, B.D. Stride, R.G. Deeley and S.P.C. Cole (1996) Location of a protease-hypersensitive region in the Multidrug Resistance Protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1. Cancer Res. 56 3307-3314.
43. D.R. Hipfner, K.C. Almquist, E.M. Leslie, J.H. Gerlach, C.E. Grant, R.G. Deeley and S.P.C. Cole (1997) Membrane topology of the multidrug resistance protein, MRP: a study of glycosylation-site mutants reveals an extracytosolic NH2-terminus. J. Biol. Chem. 272 23623-23630.
44. D.R. Hipfner, M. Gao, G. Scheffer, R. Scheper, R.G. Deeley and S.P.C. Cole (1998) Epitope mapping of monoclonal antibodies specific for the 190-kDa multidrug resistance protein (MRP). Br. J. Cancer 78 1134-1140.
45. D.R. Hipfner, R.G. Deeley and S.P.C. Cole (1999) Structural, mechanistic and clinical aspects of MRP1. Biochim. Biophys. Acta 1461 359-376.
46. D.R. Hipfner, Q. Mao, W. Qiu, E.M. Leslie, R.G. Deeley and S.P.C. Cole (1999) Monoclonal antibodies that inhibit the transport function of the 190 kDa multidrug resistance protein, MRP: localization of their epitopes to the nucleotide binding domains of the protein. J. Biol. Chem. 274 15420-15426.
47. T. Hirohashi, H. Suzuki, H. Takikawa and Y. Sugiyama (2000) ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). J. Biol. Chem. 275 2905-2910.
48. S. Hoffmeyer, O. Burk, O. von Richter, H.P. Arnold, J. Brockmoller, A. Johne, et al. (2000) Functional polymorphisms of the human multidrug resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl Acad. Sci. USA 97 3473-3478.
49. Z. Hollo, L. Homolya, C.W. Davis and B. Sarkadi (1994) Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochim. Biophys. Acta 1191 384-388.
50. J.H. Hooijberg, H.J. Broxterman, M. Heijn, D.L.A. Fles, J. Lankelma and H.M. Pinedo (1997) Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein. FEBS Lett. 413 344-348.
51. J.H. Hooijberg, H.J. Broxterman, M. Kool, Y.G. Assaraf, G.J. Peters, R.J. Schepeb, P. Borst, H.M. Pinedo and G. Jansen (1999) Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res. 59 2532-2535.
52. J.H. Hooijberg, H.M. Pinodo, C. Vrasdonk, W. Priebe, J. Lankelma and H.J. Broxterman (2000) The effect of glutathione on the ATPase activity of MRP1 in its natural membranes. FEBS Lett. 469 47-51.
53. Y.-X. Hou, L. Cui, J.R. Riordan and X.-B. Chang (2000) Allosteric interactions between the two non-equivalent nucleotide binding domains of multidrug resistance protein MRP1. J. Biol. Chem. 275 20280-20287.
54. C.A. Hrycyna, M. Ramachandra, S.V. Ambudkar, Y.H. Ko, C.L. Peebles, I. Pastan and M.M. Gottesman (1998) Mechanism of action of human P-glycoprotein ATPase activity. Photochemical cleavage during a catalytic transition state using orthovanadate reveals cross-talk between the two ATP sites. J. Biol. Chem. 273 16631-16634.
55. K. Ito, C.J. Oleschuk, C.J. Westlake, M. Vasa, R.G. Deeley and S.P.C. Cole (2001) Mutation of Trp1254 in the multispecific organic anion transporter, MRP2 (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity. J. Biol. Chem. 276 38108-38114.
56. K. Ito, S.L. Olsen, W. Qiu, R.G. Deeley and S.P.C. Cole (2001) Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport. J. Biol. Chem. 276 15616-15624.
57. S. Ito, I. Ieiri, M. Tanabe, A. Suzuki, S. Higuchi and K. Otsubo (2001) Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects. Pharmacogenetics 11 175-184.
58. G. Jedlitschky, I. Leier, U. Buchholz, M. Center and D. Keppler (1994) ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res. 54 4833-4836.
59. G. Jedlitschky, I. Leier, U. Buchholz, K. Barnouin, G. Kurz and D. Keppler (1996) Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 56 988-994.
60. G. Jedlitschky, I. Leier, U. Buchholz, J. Hummel-Eisenbeiss, B. Burchell and D. Keppler (1997) ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocytes canalicular isoform MRP2. Biochem. J. 327 305-310.
61. R.L. Juliano and V. Ling (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455 152-162.
62. J. Kartenbeck, U. Leuschner, R. Mayer and D. Keppler (1996) Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 23 1061-1066.
63. C. Kast and P. Gros (1997) Topology mapping of the amino-terminal half of multidrug resistance-associated protein by epitope insertion and immunofluorescence. J. Biol. Chem. 272 26479-26487.
64. C. Kast and P. Gros (1998) Epitope insertion favors a six transmembrane domain model for the carboxy-terminal portion of the multidrug resistance-associated protein. Biochemistry 37 2305-2313.
65. D. Keppler, G. Jedlitschky and I. Leier (1998) Transport function and substrate specificity of multidrug resistance protein. Methods Enzymol. 292 607-616.
66. R. Kim, N. Nishimoto, A. Osaki, J. Kojima, S. Fujii, K. Inai and T. Togo (2001) An analysis of relapsed breast cancer in patients previously treated with breast conserving surgery. Breast Cancer 8 146-152.
67. J. Konig, A.T. Nies, Y. Cui, I. Leier and D. Keppler (1999) Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity and MRP2-mediated drug resistance. Biochim. Biophys. Acta 1461 377-394.
68. J. Konig, Y. Cui, A.T. Nies and D. Keppler (2000) Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J. Biol. Chem. 275 23161-23168.
69. M. Kool, M. van der Linden, M. de Haas, F. Baas and P. Borst (1999) Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res. 59 175-182.
70. J. Kreisholt, M. Sorensen, P.B. Jensen, B.E. Nielsen, C.B. Andersen and M. Sehested (1998) Immunohistochemical detection of DNA topoisomerase IIα, P-glycoprotein and multidrug resistance protein (MRP) in small cell and non-small cell lung cancer. Br. J. Cancer 77 1469-1473.
71. E.U. Kurz, S.P.C. Cole and R.G. Deeley (2001) Identification of DNA-protein interactions in the 5′ flanking and 5′ untranslated regions of the human multidrug resistance protein (MRP) gene: Evaluation of a putative antioxidant response element. Biochem. Biophys. Res. Commun. 285 981-990.
72. D. Lautier, Y. Canitrot, R.G. Deeley and S.P.C. Cole (1996) Multidrug resistance mediated by the Multidrug Resistance Protein (MRP) gene. Biochem. Pharmacol. 52 967-977.
73. D. Legare, D. Richard, R. Mukhopadhyay, Y.D. Stierhof, B.P. Rosen, A. Haimeur, B. Papadopoulou and M. Ouellette (2001) The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase. J. Biol. Chem. 276 26301-26307.
74. O. Legrand, J.-Y. Perrot, R. Tang, G. Simonin, S. Gurbuxani, R. Zittoun and J.-P. Marie (1996) Expression of the multidrug resistance-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells. Br. J. Haematol. 94 23-33.
75. I. Leier, G. Jedlitschky, U. Buchholz and D. Keppler (1994) Characterization of the ATP-dependent leukotriene C4 export carrier in mastocytoma cells. Eur. J. Biochem. 220 599-606.
76. I. Leier, G. Jedlitschky, U. Buchholz, M. Center, S.P.C. Cole, R.G. Deeley and D. Keppler (1996) ATP-dependent glutathione disulfide transport mediated by the MRP geneencoded conjugate export pump. Biochem. J. 314 433-437.
77. E.M. Leslie, R.G. Deeley and S.P.C. Cole (2001) Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1), and related transporters. Toxicology 167 3-23.
78. E.M. Leslie, K. Ito, P. Upadhyaya, S.S. Hecht, R.G. Deeley and S.P.C. Cole (2001) Transport of the β-O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1): Requirement for glutathione or a nonsulfur-containing analog. J. Biol. Chem. 276 27846-27854.
79. E.M. Leslie, Q. Mao, C.J. Oleschuk, R.G. Deeley and S.P.C. Cole (2001) Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids. Mol. Pharmacol. 59 1171-1180.
80. Z. Li, M.S. Szczypka, Y. Lu, D.J. Thiele and P.A. Rea (1996) The yeast cadmium factor (YCF1) is a vacuolar glutathione S-conjugate pump. J. Biol. Chem. 271 6509-6517.
81. D.W. Loe, K.C. Almquist, S.P.C. Cole and R.G. Deeley (1996) ATP-dependent 17β-estradiol 17-(β-D-glucuronide) transport by multidrug resistance protein: inhibition by cholestatic steroids. J. Biol. Chem. 271 9683-9689.
82. D.W. Loe, K.C. Almquist, R.G. Deeley and S.P.C. Cole (1996) Multidrug Resistance Protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles: Demonstration of glutathione-dependent vincristine transport. J. Biol. Chem. 271 9675-9682.
83. D.W. Loe, R.K. Stewart, T.E. Massey, R.G. Deeley and S.P.C. Cole (1997) ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the MRP gene. Mol. Pharmacol. 51 1034-1041.
84. D.W. Loe, R.G. Deeley and S.P.C. Cole (1998) Characterization of vincristine transport by the 190 kDa multidrug resistance protein, MRP: Evidence for co-transport with reduced glutathione. Cancer Res. 58 5130-5136.
85. D.W. Loe, R.G. Deeley and S.P.C. Cole (2000) Verapamil stimulates glutathione transport by the multidrug resistance protein 1 (MPP1). J. Pharmacol. Exp. Therap. 293 530-538.
86. D.W. Loe, C.J. Oleschuk, R.G. Deeley and S.P.C. Cole (2000) Structure-activity studies of verapamil analogs that modulate transport of leukotriene C4 and reduced glutathione by multidrug resistance protein MRP1. Biochem. Biophys. Res. Commun. 275 795-803.
87. M. Lohoff, S. Prechtl, E. Sommer, M. Roellinghoff, E. Schmitt, G. Gradehandt, P. Rohwer, B.D. Stride, S.P.C. Cole and R.G. Deeley (1998) A multidrug-resistance protein (MRP)-like transmembrane pump is highly expressed by resting murine T helper (Th) 2, but not Th1 cells, and is induced to equal expression levels in Th1 and Th2 cells after antigenic stimulation in vivo. J. Clin. Invest. 101 703-710.
88. A. Lorico, G. Rappa, R.A. Flavell and A.C. Sartorelli (1996) Double knockout of the MRP gene leads to increased drug sensitivity in vitro. Cancer Res. 56 5351-5355.
89. A. Lorico, G. Rappa, R.A. Finch, D. Yang, R.A. Flavell and A.C. Sartorelli (1997) Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res. 57 5238-5242.
90. L. Ma, N. Krishnamachary and M.S. Center (1995) Phosphorylation of the multidrug resistance associated protein gene encoded protein P190. Biochemistry 34 3338-3343.
91. L. Manciu, X.-B. Chang, J.R. Riordan and J.M. Ruysschaert (2000) Multidrug resistance protein MRP1 reconstituted, into lipid vesicles: secondary structure and nucleotide-induced tertiary structure changes. Biochemistry 39 13026-13033.
92. Q. Mao, E.M. Leslie, R.G. Deeley and S.P.C. Cole (1999) ATPase activity of purified and reconstituted multidrug resistance protein MRP1 from drug-selected H69AR cells. Biochim. Biophys. Acta 1461 69-82.
93. Q. Mao, R.G. Deeley and S.P.C. Cole (2000) Functional reconstitution of substrate transport by purified multidrug resistance protein MRP1 (ABCC1) in phopholipid vesicles. J. Biol. Chem. 275 34165-34172.
94. E. Martinoia, E. Grill, R. Tommasini, K. Kreuz and N. Amrhein (1993) ATP-dependent glutathione S-conjugate ‘export’ pump in the vacuolar membrane of plants. Nature 364 247-249.
95. T.E. Massey, R.K. Stewart, J.M. Daniels and L. Liu (1995) Biochemical and molecular aspects of mammalian susceptibility to aflatoxin B1 carcinogenicity. Proc. Soc. Exp. Biol. Med. 208 1-15.
96. S.E.L. Mirski, J.H. Gerlach and S.P.C. Cole (1987) Multidrug resistance in a human small cell lung cancer cell line, selected in adriamycin. Cancer Res. 47 2594-2598.
97. K. Miyake, L. Mickley, T. Litman, Z. Zhan, R. Robey, B. Cristensen, et al. (1999) Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone resistant cells: demonstration of homology to ABC transport genes. Cancer Res. 59 8-13.
98. C.S. Morrow, S. Diah, P.K. Smitherman, E. Schneider and A.J. Townsend (1998) Multidrug, resistance protein and glutathione S-transferase P1-1, act in synergy to confer protection from 4-nitroquinoline 1-oxide toxicity. Carcinogenesis 19 109-115.
99. M. Muller, C. Meijer, G.J.R. Zaman, P. Borst, R.J. Scheper, N.H. Mulder, E.G.E. de Vries and P.L.M. Jansen (1994) Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl Acad. Sci. USA 91 13033-13037.
100. S.E. Murphy, D.A. Spina, M.G. Nunes and D.A. Pullo (1995) Glucuronidation of 4-((hydroxymethyl)nitrosamino)-1-(3-pyridyl)-1-butanone, a metabolically activated form of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, by phenobarbital-treated rats. Chem. Res. Toxicol. 8 772-779.
101. K. Nagata, M. Nishitani, M. Matsuo, N. Kioka, T. Amachi and K. Ueda (2000) Nonequivalent nucleotide trapping in the two nucleotide binding folds of the human multidrug resistance protein MRP1. J. Biol. Chem. 275 17626-17630.
102. K. Nooter, G. Brutel de la Riviere, J.G.M. Klijn, G. Stoter and J.A. Foekens (1997) Multidrug resistance protein in recurrent breast cancer. Lancet 349 1885-1886.
103. K. Nooter, G. Brutel de la Riviere, M.P. Look, K.E. van Wingerden, S.C. Henzen-Logmans, R.J. Scheper, M.J. Flens, J.G.M. Klijn, G. Stoter and J.A. Foekens (1997) The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer. Br. J. Cancer 76 486-493.
104. M.D. Norris, S.B. Bordow, G.M. Marshall, P.S. Haber, S.L. Cohn and M. Haber (1996) Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N. Engl. J. Med. 334 231-238.
105. A.-K. Ostlund Farrants, D.J. Meyer, B. Coles, C. Southan, A. Aitken, P.J. Johnson and B. Ketterer (1987) The separation of glutathione transferase subunits by using reverse-phase high-pressure liquid chromatography. Biochem. J. 245 423-428.
106. E. Ota, Y. Abe, Y. Oshika, Y. Ozeki, M. Iwasaki, H. Inoue, et al. (1995) Expression of the multidrug resistance-associated protein (MRP), gene in non-small-cell lung cancer. Br. J. Cancer 72 540-554.
107. C.C. Paulusma, M. Kool, P.J. Bosma, G.L. Scheffer, F. ter Borg, R.J. Scheper, G.N.J. Tytgat, P. Borst, F. Baas and R.P.J. Oude Elferink (1997) A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 25 1539-1542.
108. C.C. Paulusma, M.A. van Geer, R. Evers, M. Heijn, R. Ottenhoff, P. Borst and R.P.J. Oude Elferink (1999) Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem. J. 338 393-401.
109. C.M. Paumi, B.G. Ledford, P.K. Smitherman, A.J. Townsend and C.S. Morrow (2001) Role of the multidrug resistance protein 1 (MRP1) and glutathione S-transferase A1-1 in alkylating agent resistance: kinetics of gluathione conjugate formation and efflux govern differntial, cellular sensitivity to chlorambucil versus melphalan toxicity. J. Biol. Chem. 276 7952-7956.
110. K.C. Peng, F. Cluzeaud, M. Bens, J.P. Van Huyen, M.A. Wioland, R. Lacave and A. Vandewalle (1999) Tissue and cell distribution of the multidrug, resistance-associated protein (MRP) in mouse intestine and kidney. Histochem Cytochem 47 757-768.
111. W. Priebe, M. Krawczyk, M.T. Kuo, Y. Yamane, N. Savaraj and T. Ishikawa (1998) Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pumpl. Biochem. Biophys. Res. Commun. 247 859-863.
112. Y.M. Qian, W. Qiu, M. Gao, C.J. Westlake, S.P.C. Cole and R.G. Deeley (2000) Characterization of binding of leukotriene C4 by human multidrug resistance protein 1: evidence of differential interactions with NH2− and COOH-proximal halves of the protein. J. Biol. Chem. 276 38636-38644.
113. Y.M. Qian, W.C. Song, H.-R. Cui, S.P.C. Cole and R.G. Deeley (2001) Glutathione stimulate sulfated estrogen transport by multidrug resistance protein 1. J. Biol. Chem. 276 6404-6411.
114. M. Ramachandra, S.V. Ambudkar, D. Chen, C.A. Hrycyna, S. Dey, M.M. Gottesman and I. Pastan (1998) Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic, transition state. Biochemistry 37 5010-5019.
115. G. Rappa, R.A. Finch, A.C. Sartorelli and A. Lorico (1999) New insights into the biology, and pharmacology of the multidrug resistance protein (MRP) from gene knockout models. Biochem. Pharmacol. 58 557-562.
116. P.A. Rea, Z. Li, Y. Lu, Y.M. Drozdowicz and E. Martinoia (1998) From vacuolar GS-X pumps to multispecific ABC transporters. Annu. Rev. Plant Physiol. Plant Mol. Biol. 49 727-760.
117. J.G. Reeve, P.H. Rabbitts and P.R. Twentman (1990) Non-P-glycoprotein-mediated multidrug resistance with reduced EGF receptor expression in a human large cell lung cancer cell line. Br. J. Cancer. 61 851-855.
118. X.Q. Ren, T. Furukawa, Z. Chen, H. Okumura, S. Aoki, T. Sumizawa, A. Tani, M. Komatsu, X.D. Mei and S. Akiyama (2000) Functional comparison between YCF1 and MRP1 expressed in Sf21 insect cells. Biochem. Biophys. Res. Commun. 270 608-615.
119. X.Q. Ren, T. Furukawa, S. Aoki, T. Nakajima, T. Sumizawa, M. Haraguchi, Z. Chen, M. Kobayashi and S. Akiyama (2001) Glutathione-dependent binding of a photoaffinity analog of Agosterol A to the C-terminal half of human multidrug resistance protein. J. Biol. Chem. 276 23197-23206.
120. J. Renes, E.G.E. de Vries, E.F. Nienhuis, P.L.M. Jansen and M. Muller (1999) ATP-and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1. Br. J. Pharmacol. 126 681-688.
121. J. Renes, E.G.E. de Vries, G.J.E.J. Hooiveld, I. Krikken, P.L.M. Jansen and M. Muller (2000) Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal. Biochem. J. 350 555-561.
122. F. Ringpgeil, M.G. Lebwohl, N.M. Christiano and J. Uitto (2000) Pseudoxanthoma elasticum: Mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc. Natl Acad. Sci. USA 97 6001-6006.
123. H. Roelofsen, T.A. Vos, I.J. Schippers, F. Kuipers, H. Koning, H. Moshage, P.L.M. Jausen and M. Muller (1997) Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells. Gastroenterology 112 511-521.
124. M.F. Rosenberg, R. Callaghan, R.C. Ford and C.F. Higgins (1997) Structure of the multidrug resistance P-glycoprotein to 2.5nm resolution determined by electron microscopy and image analysis. J. Biol. Chem. 272 10685-10694.
125. M.F. Rosenberg, O. Mao, A. Holzenburg, R.O. Drelen and S.P.T. Cole (2001) The structure of the multidrug resistance protein 1 (MRP1/ABCC1): crystallization and single-particle analysis. J. Biol. Chem. 276 16076-16082.
126. N. Saifou and M. Nei (1987) The neighbourjoining method: a new method for reconstruction of phylogenetic trees. Mol. Biol. Evol. 4 406-425.
127. H. Sakamoto, H. Hara, K. Hirano and E. Adachi (1999) Enhancement of glucuronosyl etoposide transport by glutathione in multidrug resistance-associated protein-overexpressing cells. Cancer Lett. 135 113-119.
128. M.J. Schultz, J. Wijnholds, M.P. Peppelenbosch, M.J.B.M. Vervoodeldonk, P. Speelman, S.J.H. van Deventer, P. Borst and T. van den Poll (2001) Mice lacking the multidrug resistance protein 1 are resistant to Streptococcus pneumoniae-induced pneumonia. J. Immunol. 166 4059-4064.
129. A.E. Senior, M.K. Al-Shawi and I.L. Urbatsch (1995) The catalytic cycle of P-glycoprotein. FEBS Lett 377 285-289.
130. S.S. Sethna, J.E. Gander and W.B. Rathbun (1984) Glutathione synthetase of bovine lens: anomalies of the enzyme-catalyzed formation of ophthalmic acid. Curr. Eye Res. 3 923-928.
131. A.B. Shapiro and V. Ling (1997) Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur. J. Biochem. 250 130-137.
132. F.J. Sharom, R. Liu, Y. Romsicki and P. Lu (1999) Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies. Biochim. Biophys. Acta 1461 327-345.
133. C.A. Slapak, J.C. Daniel and S.B. Levy (1990) Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: decreased anthracycline uptake precedes increased P-glycoprotein expression. Cancer Res. 50 7895-7901.
134. M.L. Slovak, J.P. Ho, G. Bhardwaj, E.U. Kurz, R.G. Deeley and S.P.C. Cole (1993) Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. Cancer Res. 53 3221-3225.
135. M. Sozynski, A. Kaluzna, B. Rychlik, A. Sokal and G. Bartosz (1998) Radiation inactivation suggests that human multidrug resistance-associated protein 1 occurs as a dimer in the human erythrocyte membrane. Arch. Biochem. Biophys. 354 311-316.
136. M.V. St. Pierre, M.E. Serrano, R.I.R. Macias, U. Dubs, M. Hoechli, U. Lauper, P.J. Meier and J.J.G. Marin (2000) Expression of members of the multidrug resistance protein family in human term placenta. Am. J. Physiol. 279 R1495-R1503.
137. B.D. Stride, G. Valdimarsson, J.H. Gerlach, G.M. Wilson, S.P.C. Cole and R.G. Deeley (1996) Structure and expression of the mRNA encoding the murine multidrug resistance protein (MRP), an ATP-binding cassette transporter. Mol. Pharmacol. 49 962-971.
138. B.D. Stride, C.E. Grant, D.W. Loe, D.R. Hipfner, S.P.C. Cole and R.G. Deeley (1997) Pharmacological characterization of the murine and human orthologs of multidrug resistance protein in transfected human embryonic kidney cells. Mol. Pharmacol. 52 344-353.
139. B.D. Stride, S.P.C. Cole and R.G. Deeley (1999) Localization of a substrate specificity domain in the multidrug resistance protein. J. Biol. Chem. 274 22877-22883.
140. G.F. Sullivan, P.S. Amenta, J.D. Villanueva, C.J. Alvarez, J. Yang and W.N. Hait (1998) The expression of drug resistance gene products during the progression of human prostate cancer. Clin. Cancer Res. 4 1393-1403.
141. K. Szabo, E. Welker, E. Bakos, M. Muller, I. Roninson, A. Varadi and B. Sarkadi (1998) Drug-stimulated nucleotide trapping in the human multidrug transporter MDR1Cooperation of the nucleotide binding domains. J. Biol. Chem. 273 10132-10138.
142. R. Tommasini, R. Evers, E. Vogt, C. Mornet, G.J.R. Zaman, A.H. Schinkel, P. Borst and E. Martinoia (1996) The human multidrug resistance-associated protein functionally complements the yeast cadmium resistance factor 1. Proc. Natl Acad. Sci. USA 93 6743-6748.
143. K. Ueda, Y. Taguchi and M. Morishima (1997) How does P-glycoprotein recognize its substrates? Semin. Cancer Biol. 8 151-159.
144. D.M. van der Kolk, E.G.E. de Vries, W.J. van Butten, L.F. Verdonck, G.J. Ossenkoppele, G.E. Verhoef and E. Vellenga (2000) P-glycoprotein and multidrug resistance protein activities in relation to treatmet outcome in acute myeloid leukemia. Clin. Cancer Res. 6 3205-3214.
145. M.J.A. van Luyn, M. Muller, J. Renes, C. Meijer, R.J. Scheper, E.F. Nienhuis, N.H. Mulder, P.L.M. Jansen and E.G.E. de Vries (1998) Transport of glutathione conjugates into secretory vesicles is mediated by the multidrug-resistance protein 1. Int. J. Cancer 76 55-62.
146. H.W. van Veen, A. Margolles, M. Muller, C.F. Higgins and W.N. Konings (2000) The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism. EMBO J. 19 2503-2514.
147. L. Vernhet, A. Courtois, N. Allain, L. Payen, J.-P. Anger, A. Guiltenzo and O. Fardel (1999) Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells. FEBS Lett. 443 321-325.
148. C.H.M. Versantvoort, I. Bagrij, K.A. Wright and P.R. Twentyman (1995) On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP). Int. J. Cancer 63 855-862.
149. C.H.M. Versantvoort, H.J. Broxterman, T. Bagrij, R.J. Scheper and P.R. Twentyman (1995) Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br. J. Cancer 72 82-89.
150. T.A. Vos, G.J.E.J. Hooiveld, H. Koning, S. Childs, D.K.F. Meijer, H. Moshage, P.L.M. Jansen and M. Muller (1998) Upregulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 28 1637-1644.
151. J. Wijnholds, R. Evers, M.R. Van Leusden, C.A.A.M. Mol, G.J.R. Zaman, U. Mayer, J.H. Beijnen, M. van der Valk, P. Krimpenfort and P. Borst (1997) Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat. Med. 3 1275-1279.
152. J. Wijnholds, G.L. Scheffer, M. van der Valk, P. van der Valk, J. Beijnen, R.J. Scheper and P. Borst (1998) Multidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage. J. Exp. Med. 188 797-808.
153. J. Wijnholds, E.C.M. de Lange, G.L. Scheffer, D.-J. van den Berg, C.A.A.M. Mol, M. van der Valk, A.H. Schinkel, R.J. Scheper, D.D. Breimer and P. Borst (2000) Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J. Clin. Invest. 105 279-285.
154. S.R. Wright, A.H. Boag, B.G. Campling, G. Valdimarsson, D.R. Hipfner, S.P.C. Cole and R.G. Deeley (1998) Immunohistochemical detection of multidrug resistance protein (MRP) in human lung cancer and normal lung. Clin. Cancer Res. 4 2279-2289.
155. Y. Yamane, M. Furuichi, R. Song, N.T. Van, R.T. Mulcahy, T. Ishikawa and M.T. Kuo (1998) Expression of multidrug resistance protein/GS-X pump and gamma-glutamyl-cysteine synthetase genes is regulated by oxidative stress. J. Biol. Chem. 273 31075-31085.
156. G.J.R. Zaman, J. Lankelma, O. van Tellingen, J. Beijnen, H. Dekker, C. Paulusma, R.P.J. Oude Elferink, E. Baas and P. Borst (1996) Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc. Natl. Acad. Sci. USA 92 7690-7694.
157. H. Zeng, Z.-S. Chen, M.G. Belinsky, F.A. Rea and G.D. Kruh (2001) Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Res. 61 7225-7232.
158. D. Zhang, S.P.C. Cole and R.G. Deeley (2001) Identification of a non-conserved amino acid residue in Multidrug Resistance Protein (MRP) 1 important for determining substrate specifity: evidence for functional interaction between transmembrane helices 14 and 17. J. Biol. Chem. 276 34966-34974.
159. D. Zhang, S.P.C. Cole and R.G. Deeley (2001) Identification of an amino acid residue in multidrug resistance protein (MRP) 1 critical for conferring resistance to anthracyclines. J. Biol. Chem. 276 13231-13239.
160. Q. Zhu and M.S. Center (1994) Cloning and sequence analysis of the promoter region of the MRP gene ofHL60 cells isolated for resistance to Adriamycin. Cancer Res. 54 4488-4492.
161. Q. Zhu and M.S. Center (1996) Evidence that SP1 modulates transcriptional activity of the multidrug resistance-associated protein gene. DNA Cell Biol. 15 105-111.